Analysis of AMH as a diagnostic test for POI at 24 months after diagnosis indicated substantially greater accuracy than in a previous similar analysis in women treated for breast cancer when AMH was measured using a less sensitive assay [26]. This evidence concerns the gene AMH and breast carcinoma.